Charles Schwab Investment Management Inc Uni Qure N.V. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 277,275 shares of QURE stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

277,275

Previous 260,811 6.31%

Holding current value

$1.6 Million

Previous $1.17 Million 16.95%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.78 - $10.12 $62,233 - $166,615	16,464 Added 6.31%	277,275 $1.37 Million
Q2 2024 Aug 12, 2024	BUY	$4.39 - $5.43 $111,159 - $137,493	25,321 Added 10.75%	260,811 $1.17 Million
Q1 2024 May 08, 2024	BUY	$4.82 - $6.93 $63,146 - $90,789	13,101 Added 5.89%	235,490 $1.22 Million
Q4 2023 Feb 06, 2024	SELL	$5.63 - $8.27 $104,847 - $154,012	-18,623 Reduced 7.73%	222,389 $1.51 Million
Q3 2023 Nov 08, 2023	BUY	$6.71 - $11.83 $127,389 - $224,592	18,985 Added 8.55%	241,012 $1.62 Million
Q2 2023 Aug 09, 2023	BUY	$11.12 - $22.2 $33,437 - $66,755	3,007 Added 1.37%	222,027 $2.54 Million
Q1 2023 May 11, 2023	SELL	$18.7 - $23.07 $10,079 - $12,434	-539 Reduced 0.25%	219,020 $4.41 Million
Q4 2022 Feb 13, 2023	BUY	$18.12 - $27.32 $132,384 - $199,599	7,306 Added 3.44%	219,559 $4.98 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $555,008 - $834,800	32,686 Added 18.2%	212,253 $3.98 Million
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $27,733 - $43,129	-2,109 Reduced 1.16%	179,567 $3.35 Million
Q1 2022 May 13, 2022	BUY	$14.54 - $21.5 $65,051 - $96,191	4,474 Added 2.52%	181,676 $3.28 Million
Q4 2021 Feb 11, 2022	BUY	$20.24 - $36.01 $41,775 - $74,324	2,064 Added 1.18%	177,202 $3.68 Million
Q3 2021 Nov 16, 2021	SELL	$26.01 - $38.22 $200,667 - $294,867	-7,715 Reduced 4.22%	175,138 $5.61 Million
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $194,445 - $241,158	6,488 Added 3.68%	182,853 $5.63 Million
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $221,463 - $318,335	7,574 Added 4.49%	176,365 $5.94 Million
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $80,562 - $115,476	2,279 Added 1.37%	168,791 $6.1 Million
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $5.99 Million - $7.94 Million	166,512 New	166,512 $6.13 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Uni Qure N.V. Transaction History